Stock Trading Canary

United States · SEC Form 4 · Snapshot date: 2026-10-18 · Built: 2026-10-18 · 中文

← United States · Coverage record

US · SEC FORM 4

PharmaCyte Biotech, Inc.

PMCB · Nasdaq · CIK 0001157075 · Healthcare · Biotechnology

INSIDER SIGNAL

No active buy signal

0 qualifying P purchase groups
in the current 180-day scoring window

0 Form 4 transaction lines observed in the same window
0 sales · 0 option, withholding, award, gift or other lines

Last qualifying purchase2026-01-07 · Silverman Joshua · $33.2K

WHY NO ACTIVE SIGNAL?

Purchase activityNone
Recent buyingNone
Recent salesNone
Buy signal statusInactive
Score anatomy

No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.

ClusterNot calculated
Purchase sizeNot calculated
RoleNot calculated
RecencyNot calculated
ConvictionNot calculated

Why is there no score?

  • No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
  • Sales and other Form 4 activity remain visible as context and do not create a negative score.

Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.

Insider activity timeline

No Form 4 transaction event is present in the current 180-day window.

Purchase breadth, concentration & cluster buying

These modules activate when qualifying purchases enter the 180-day research window.

SIGNAL HISTORY

No recorded active-signal snapshot

Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2026-01-07 · Silverman Joshua.

Recent Form 4 activity

6Purchases
0Sales
10Other Form 4 lines
7SEC filings · 365 days
BUYING0 qualifying P line(s) · 180 days
SELLING0 sale line(s) · context only
OTHER0 exercise / withholding / award / gift / other lines
10b5-1 / PLANNEDNot assessed

P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.

Market context

Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.

Short interest

Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.

Shares short
133,885
Previous report
70,436
Avg daily volume
533,557
Days to cover
≤ 1.0

FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.

Historical equity purchases

Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.

Transaction dateReporting ownerTypeSecuritySharesAvg. priceApprox. valueSource
2026-01-07Silverman JoshuaPurchase (P)Common Stock40,000USD 0.83USD 33,200SEC filing ↗
2026-01-07SCHECHTER JONATHANPurchase (P)Common Stock20,000USD 0.84USD 16,800SEC filing ↗
2026-01-06Silverman JoshuaPurchase (P)Common Stock30,000USD 0.79USD 23,700SEC filing ↗
2026-01-06SCHECHTER JONATHANPurchase (P)Common Stock20,000USD 0.79USD 15,800SEC filing ↗
2026-01-05Silverman JoshuaPurchase (P)Common Stock30,000USD 0.78USD 23,400SEC filing ↗
2026-01-05SCHECHTER JONATHANPurchase (P)Common Stock20,000USD 0.78USD 15,600SEC filing ↗

Form 4 evidence

16 transaction lines in the latest 365-day window; 16 in local history.

DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-01-07Silverman JoshuaPurchase (P)Common Stock40,000USD 0.83USD 33,200SEC filing ↗
2026-01-07SCHECHTER JONATHANPurchase (P)Common Stock20,000USD 0.84USD 16,800SEC filing ↗
2026-01-06Silverman JoshuaPurchase (P)Common Stock30,000USD 0.79USD 23,700SEC filing ↗
Show recent Form 4 evidence (16 grouped rows)
DateOwnerTypeSecuritySharesAvg. priceApprox. valueSource
2026-01-07Silverman JoshuaPurchase (P)Common Stock40,000USD 0.83USD 33,200SEC filing ↗
2026-01-07SCHECHTER JONATHANPurchase (P)Common Stock20,000USD 0.84USD 16,800SEC filing ↗
2026-01-06Silverman JoshuaPurchase (P)Common Stock30,000USD 0.79USD 23,700SEC filing ↗
2026-01-06SCHECHTER JONATHANPurchase (P)Common Stock20,000USD 0.79USD 15,800SEC filing ↗
2026-01-05Silverman JoshuaPurchase (P)Common Stock30,000USD 0.78USD 23,400SEC filing ↗
2026-01-05SCHECHTER JONATHANPurchase (P)Common Stock20,000USD 0.78USD 15,600SEC filing ↗
2025-12-12WEINSTEIN ROBERTTax withholding (F)Common Stock33,750USD 1.02USD 34,425SEC filing ↗
2025-12-12WEINSTEIN ROBERTAward / grant (A)Common Stock75,000USD 0.00USD 0SEC filing ↗
2025-12-12WALKER WAYNE REMELLTax withholding (F)Common Stock16,875USD 1.02USD 17,212SEC filing ↗
2025-12-12WALKER WAYNE REMELLAward / grant (A)Common Stock37,500USD 0.00USD 0SEC filing ↗
2025-12-12Silverman JoshuaTax withholding (F)Common Stock258,750USD 1.02USD 263,925SEC filing ↗
2025-12-12Silverman JoshuaAward / grant (A)Common Stock575,000USD 0.00USD 0SEC filing ↗
2025-12-12SCHECHTER JONATHANTax withholding (F)Common Stock67,500USD 1.02USD 68,850SEC filing ↗
2025-12-12SCHECHTER JONATHANAward / grant (A)Common Stock150,000USD 0.00USD 0SEC filing ↗
2025-12-12Abecassis Michael MTax withholding (F)Common Stock16,875USD 1.02USD 17,212SEC filing ↗
2025-12-12Abecassis Michael MAward / grant (A)Common Stock37,500USD 0.00USD 0SEC filing ↗

Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.

Snapshot & identity

Snapshot date2026-10-18
Ranking versionUS-v1.2
Data qualityPASS ELIGIBLE · —
TickerPMCB
CIK0001157075
SectorHealthcare
IndustryBiotechnology Yahoo Finance
SEC SIC2836 Biological Products, (No Diagnostic Substances)
ExchangeNasdaq

Data coverage

Local Form 4 history16 transaction lines from 2025-12-12 to 2026-01-07
6 P purchase lines · 0 S sale lines · 10 other lines
SEC company submissionsOpen SEC filings ↗

Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.